A graduate of the University of Missouri-Kansas City School of Medicine, Dr. Rajiv “Raj” Dahiya has worked at a number of facilities during his career, including at Predictive Medical Solutions, before taking his current job as a radiation oncologist at Premier Cancer Centers in Dallas, TX. Outside of his work as an MD, Dr. Raj Dahiya helps in the fight against cancer by supporting the efforts of the American Cancer Society.According to researchers with the American Cancer Society, changes to screening recommendations which initially led to a decline in prostate specific antigen (PSA) tests now have less of an impact, with the decline now tapering off. When the US Preventive Services Task Force issued its recommendations against PSA testing in 2008, rates dropped by seven percent over a three-year period in men over the age of 50.Recent research shows, however, that the screening rate has stabilized since 2015, with approximately 32.1 percent of men aged 50-plus receiving PSA screenings. Researchers attribute the stabilization to recent research indicating that older men are being diagnosed with prostate cancer at a slightly increased rate, prompting more men to get screened and others to be screened more frequently.
In Dallas, TX, Dr. Rajiv (Raj) Dahiya uses minimally invasive technologies including the Predictive Medical Solutions Cyberknife in his work as a radiation oncologist. Dr. Raj Dahiya holds an MD from the University of Missouri-Kansas City School of Medicine, is a diplomate of the American Board of Radiology, and maintains a membership with the American College of Radiology. The American College of Radiology is a voluntary professional organization for radiologists and other physicians and scientists who practice and advance radiologic care. The nonprofit organization works to advance radiology by supporting these radiological professionals and those who benefit from their efforts.The American College of Radiology often focuses on advocacy work related to public policy matters. It has recently been working to expand access to CT lung cancer screenings for Medicare patients. Data gathered in the National Lung Screening Trial shows that patients who receive these screenings annually experience a 20 percent lower rate of lung cancer mortality. These exams are highly cost effective, but not always covered for Medicare patients. The American College of Radiology has successfully helped many high-risk patients access screenings, but many more remain unable to obtain this preventive service.
